Whipplewood Advisors, LLC Argenx Se Transaction History
Whipplewood Advisors, LLC
- $176 Billion
- Q4 2024
A detailed history of Whipplewood Advisors, LLC transactions in Argenx Se stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 60 shares of ARGX stock, worth $39,078. This represents 0.02% of its overall portfolio holdings.
Number of Shares
60Holding current value
$39,078% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
416Shares Held
31MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.79 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.29 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.61 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.11 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$807 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $36B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...